Furthermore, serum AFP levels improved in 16 patients, with a remarkable decrease observed in those with an initial AFP below 100 ng/mL Tumor control, preserved liver function, and reduced platelet count were commonly observed in this cohort. This evidence concerns the gene AFP and neoplasm.